| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | — | +62.6% |
| R&D Expense | $8.7M | — | -26.1% |
| SG&A Expense | $5.1M | — | -48.4% |
| Operating Income | -$12.1M | — | +70.8% |
| Pre-tax Income | -$21.2M | — | +57.0% |
| Income Tax | $7K | — | +250.0% |
| Net Income | -$21.2M | — | +54.7% |
| EPS (Basic) | -$0.33 | — | +75.4% |
| EPS (Diluted) | -$0.33 | — | +75.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.3M | +205.6% | +28.6% |
| Accounts Receivable | $1.7M | +238.6% | +79.3% |
| Current Assets | $33.1M | +174.0% | +27.8% |
| Total Assets | $324.2M | +6.3% | -3.2% |
| Current Liabilities | $13.9M | -17.3% | -33.6% |
| Long-term Debt | $73K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.5M | — | +2.9% |
| Capital Expenditures | $115K | — | -60.5% |
| Investing Cash Flow | -$72K | — | +75.3% |
| Financing Cash Flow | $32.0M | — | +50.3% |
| Free Cash Flow | -$11.6M | — | +4.3% |
| -59.4% |
| Total Liabilities | $288.7M | +1.9% | +10.6% |
| Stockholders' Equity | $35.5M | +62.5% | -49.5% |